EMEA-000916-PIP01-10-M06

Key facts

Invented name
Lyxumia
Active substance
lixisenatide
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0380/2018
PIP number
EMEA-000916-PIP01-10-M06
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of type-2 diabetes mellitus
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Sanofi-Aventis R&D

E-mail: contact-us@sanofi.com
Tel. +33 1697 45264

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating